Synthesis of N-Protected 3,3-Difluoroazetidin-2-ones

Abstract

Representative N-protected 3,3-difluoroazetidin-2-ones 3 were obtained, either in one step by cycloaddition of zinc enolate 1 derived from ethyl bromodifluoroacetate onto N,N′,N′′-trisubstituted hexahydro-1,3,5-triazines 2 (Schiff base trimer) in the case of 3a [N-(p-methoxybenzyl) derivative], or in two steps consisting of a Reformatsky-type reaction for the preparation of N-substituted 3-amino-2,2-difluoropropanotes 8 followed by N1-C2 cyclization under basic conditions in the cases of 3b (N-anisyl derivative) and 3c (N-benzhydryl derivative).

Key words

fluoroazetidinone - Reformatsky-type reaction - cycloaddition - cyclization

References

• 1 Filler R. Kobayashi Y. Yagupolskii LM. Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications   Elsevier; Amsterdam: 1993. 
• 2 Kukhar VP. Soloshonok VA. Fluorine-Containing Amino Acids. Synthesis and Properties   Wiley; Chichester: 1995. 
• 3 Kitazume T. Yamazaki T. Experimental Methods in Organic Fluorine Chemistry   Gordon and Breach; Kodansha Tokyo: 1998. 
• 4 Taguchi T. Kitagawa O. Suda Y. Ohkawa S. Hashimoto A. Iitaka Y. Kobayashi Y. Tetrahedron Lett.  1988,  29:  5291 
• 5 Baldwin JE. Lynch GP. Schofield CJ. Tetrahedron  1992,  48:  9085 
• 6 Angelastro MR. Bey P. Mehdi S. Peet NP. Bioorg. Med. Chem. Lett.  1992,  2:  1235 
• 7 Marcotte S. Pannecoucke X. Feasson C. Quirion JC. J. Org. Chem.  1999,  64:  8461 
• 8 Thaisrivongs S. Schostarez HJ. Pals DT. Turner SR. J. Med. Chem.  1987,  30:  1837 
• 9 Iseki K. Kuroki Y. Asada D. Takahoshi M. Kishimoto S. Kobayashi Y. Tetrahedron  1997,  53:  10271 
• 10 Nakayama K. Kawato HC. Inagaki H. Nakajima R. Kitamura A. Someya K. Ohta T. Org. Lett.  2000,  2:  977 
• 11 Otaka A. Watanabe H. Mitsuyama E. Yukimasa A. Tamamura H. Fuji N. Tetrahedron Lett.  2001,  42:  285 
• 12 Joyeau R. Molines H. Labia R. Wakselman M. J. Med. Chem.  1988,  31:  370 
• 13 Wakselman M. Joyeau R. Kobaiter R. Bogetto N. Vergely I. Maillard J. Okochi V. Montagne J.-J. Reboud-Ravaux M. FEBS Lett.  1991,  282:  377 
• 14 Vergely I. Bogetto N. Okochi V. Golpayegani S. Reboud-Ravaux M. Kobaiter R. Joyeau R. Wakselman M. Eur. J. Med. Chem.  1995,  30:  199 
• 15 Cheguillaume A. Lacroix S. Marchand-Brynaert J. Tetrahedron Lett.  2003,  43:  2375 
• 16 Kocienski PJ. Protecting Groups   2nd ed.:  Thieme; Stuttgart: 2000. 
• 17 Laurent M. Belmans M. Kemps L. Cérésiat M. Marchand-Brynaert J. Synthesis  2003,  570 
• 18 Shiozaki M. Masuko H. Heterocycles  1984,  22:  1727 
• 19 Rivera A. Torres OL. Jesus D. Morales-Rios MS. Joseph-Nathan P. Synth. Commun.  2002,  32:  1407 
• 20 Steere JA. Sampson PB. Honek JF. Bioorg. Med. Chem. Lett.  2002,  12:  457 
• 21 Kobayashi S. Iiomori T. Izawa T. Ohno M. J. Am. Chem. Soc.  1981,  103:  2406 
• 22 Huang H. Iwasawa N. Mukaiyama T. Chem. Lett.  1984,  1465 
• 23 Murayama T. Kobayashi T. Miura T. Tetrahedron Lett.  1995,  36:  3703 
• 24 Ogilvie WW. Yoakim C. Dô F. Haché B. Lagacé L. Naud J. O’Meara JA. Déziel R. Bioorg. Med. Chem.  1999,  7:  1521 
• 25 Katritzky AR. Rachwal S. Rachwal B. J. Chem. Soc., Perkin Trans.1  1987,  799 
• 26 Katritzky AR. Nichols DA. Qi M. Tetrahedron Lett.  1998,  39:  7063 
• 27 Gérard S. Nollet G. Vande Put J. Marchand-Brynaert J. Bioorg. Med. Chem.  2002,  10:  3955